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ABSTRACT
Background: It has been hypothesized that monosodium glutamate
(MSG), a flavor enhancer, is positively associated with weight gain,
which influences energy balance through the disruption of the hy-
pothalamic signaling cascade of leptin action.
Objective: The objective was to examine the longitudinal associa-
tion between MSG consumption and incidence of overweight.
Design: Data were collected from the China Health and Nutrition
Survey (CHNS), a prospective open-cohort, ongoing nationwide
health and nutrition survey, consisting of 10,095 apparently healthy
Chinese adults aged 18–65 y at entry from 1991 to 2006. Diet,
including MSG and other condiments, was assessed with a weighed
food inventory in combination with three 24-h recalls. Incident
overweight was defined as a body mass index (BMI; in kg/m2)  25
or 23 based on World Health Organization recommendations for
Asian populations. Multilevel mixed-effects models were con-
structed to estimate change in BMI, and Cox regression models
with gamma shared frailty were used to determine the incidence of
overweight.
Results: The mean follow-up was 5.5 y. The cumulative mean
(6SD) MSG intake of 2.2 6 1.6 g/d was positively associated with
BMI after adjustment for potential confounders and cluster effects
at different levels (individual, household, and community). The
adjusted hazard ratio of overweight was 1.33 (95% CI: 1.01, 1.75;
P for trend , 0.01) for participants in the highest quintile of MSG
intake compared with those in the lowest quintile after adjustment
for age, physical activity, total energy intake, and other major life-
style factors.
Conclusions: MSG consumption was positively, longitudinally as-
sociated with overweight development among apparently healthy
Chinese adults. Additional studies are needed to elucidate mecha-
nisms of action and to establish causal inference. Am J Clin
Nutr 2011;93:1328–36.
INTRODUCTION
As a flavor enhancer, monosodium glutamate (MSG), also
called umami, has been used for 100 y in household food
preparation and commercially processed foods. For decades, it
was believed that MSG was only used in Asian cuisine. Today,
MSG has become one of the world’s most widely used food
additives. It exists in most processed foods, but may be hidden on
ingredient labels and listed under other names (1, 2). According
to the available data, large variations exist in MSG consumption
within and across populations. The US Food and Drug
Administration’s (FDA’s) Generally Recognized as Safe (GRAS)
Committee reported a mean daily intake of MSG per capita of
550 mg/d in the United States in 1979 (3). A survey published in
1991 found an average intake of 580 mg/d for the general
population and 4.68 g/d for extreme users (97.5th percentile
consumers) in the United Kingdom (4). In Japan and Korea, the
estimated averageMSG intake in the 1990s was 1.2–1.7 g/d (5). It
is speculated, however, that the average daily MSG intake may be
up to 10 g/d (5, 6). Of note, MSG intakes in previous studies were
likely underestimated because of missing data onMSG content in
processed foods.
Concern has been raised about MSG as a risk factor for ep-
idemic obesity because data from both animal models (7–10) and
human studies (11, 12) suggest a possible link between MSG and
overweight/obesity. Potential mechanisms for the MSG-obesity
link include the possible influence of MSG on energy balance by
increasing palatability (13, 14) and by disrupting the hypotha-
lamic signaling cascade of leptin action (15, 16). The longitudinal
association between MSG consumption and incidence of over-
weight/obesity, however, is unclear. Therefore, we prospectively
examined MSG intake in relation to incidence of overweight and
change in body mass index (BMI) in 10,095 apparently healthy
Chinese adults from the China Health and Nutrition Survey
(CHNS)—a longitudinal open-cohort, ongoing, nationwide survey
that has available MSG data. The primary purpose of collecting
MSG data in the CHNS was to study association between sodium
intake and hypertension.
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SUBJECTS AND METHODS
Study sample
Details of the CHNS are described elsewhere (17). Briefly, this
cohort was established in 1989 and includes participants from 9
provinces, which vary substantially in geography, stage of eco-
nomic development, and health status. Four counties within each
province (1 low-, 2middle-, and 1 high-income based on per-capita
income reported by the National Bureau of Statistics) were ran-
domly selected by using a weighted sampling scheme. In addition,
a large higher-income city along with a lower-income city was
selected. Villages and townships within the counties and urban and
suburban neighborhoods within the cities were selected randomly,
for a total of 190 primary sampling units at baseline. Twenty
randomly selected households were surveyed within each unit, and
all individuals within a household were interviewed. The CHNS
was conducted in 1989, 1991, 1993, 1997, 2000, 2004, and 2006.
In the present study, data from the 1989 survey were not used
because only children younger than 7 y and young adults aged
20–45 y were surveyed in that year because of funding con-
straints. From the 1991–2006 surveys, 10,185 participants aged
18–65 ywhen they entered into the survey hadMSGdata available.
Of them, we excluded pregnant women (n = 84) and those who
had an implausible daily MSG intake (.10 g/d; n = 6). A total
of 10,095 Chinese men and women remained in the analyses.
Survey protocols, instruments, and the process for obtaining
informed consent for this study were approved by the institutional
review committees of the University of North Carolina at Chapel
Hill and the National Institute of Nutrition and Food Safety,
China Center for Disease Control and Prevention. All participants
gave their written informed consent.
Dietary measurement
Dietary data were collected at both the household and in-
dividual levels. Household food consumption was determined by
conducting a detailed examination of changes in inventory from
the beginning to the end of each day for 3 consecutive days (2
weekdays and 1 weekend day) in combination with a weighing
technique (18, 19). Digital diet and kitchen scales with a maxi-
mum limit of 3 kg and a minimum of 1 g were used to weigh the
food. All purchases, home production, and processed snack foods
wereweighed and recorded. Preparation waste (eg, spoiled rice or
discarded cooked meals fed to pets or animals) was estimated
when weighing was not possible. At the end of the survey, all
remaining foods were again weighed and recorded.
Dietary intake at the individual level was assessed by using 24-h
recalls for the same 3 consecutive days. Individuals were asked to
report all food consumed away from home and at home in a 24-h
recall day. We linked individual food consumption with household
consumption based on the percentage of individual consumption
of any food as a proportion of what the household consumed. Also,
we adjusted individual reported consumption by the amount
weighed at the household level if there was a large difference in
consumption between the household and individual levels (18).
MSG intake assessment and validation
In the CHNS, MSG was directly measured as part of the very
detailed, in-depth dietary data collection. In each household,
MSG, soy sauce, and all other condiments were weighed before
and after the 24-h recall. The household MSG consumption was
calculated as the difference between the 2 weights. MSG intake
for each household member was estimated based on the pro-
portion of each individual’s food consumption.
The estimation of MSG intake for each household has been
found to be accurate because we directly weighed consumed
MSG and soy sauce. To evaluate the accuracy of MSG intake at
the individual level, we conducted a validation study using ri-
boflavin as an adherence marker (20) of MSG intake to estimate
the proportion of MSG consumed by each household member.
Six households were selected from one community in Zhenjiang,
Jiangsu Province, for validating MSG intake. To ensure that all
participants were saturated with riboflavin, selected participants
were given 5 mg of over-the-counter riboflavin once per day for
5 d before the validation study. The MSG container was weighed
before and after each of the three 24-h recalls. In addition, 24-h
urine samples were collected for all participants in these 3 d.
MSG intakes for individuals were estimated based on self-reported
proportion of food consumption in the recalls and were also
calculated based on the proportion of urinary riboflavin excretion
among householdmembers. The Spearman’s correlation coefficient
between individual MSG intake assessed from three 24-h recalls
combined with a detailed weighing and MSG measurement by
using urinary riboflavin marker was 0.82 (P , 0.01). This val-
idation study suggests that individual MSG intake assessed by
using three 24-h recalls and direct weighing in the CHNS is
reliable and informative at least for ranking participants and
estimating relative risks. To reduce the effect of random within-
person variation, the mean of 3-d MSG intake was used in the
analysis.
Validation of total energy intake
The total energy intake estimated by the methods of directly
weighing foods and three 24-h recalls was evaluated previously in
73 weight-stable Chinese men and women aged 35–49 y (21).
The reported total energy intake calculated from the 3-d weighed
food intake was compared with the total energy expenditure
determined with the use of the doubly labeled water method. The
correlation coefficient was 0.56 (P , 0.01) for men and 0.60
(P , 0.01) for women (21). The findings from this validation
study indicate that the measurement on total energy intake in the
CHNS was as good as or better than other established diet
measurement instruments used in the United States.
Measurements of physical activity and other covariates
The CHNS has comprehensive data on physical activity (22–
25). Occupational activity was measured by using self-reported
occupation(s) and the average number of hours spent working per
week in the past year for up to 2 market-sector jobs as well as
hours worked from home. Participants were also asked about the
activity levels of their occupations, which interviewers catego-
rized into 5 levels (very light, light, moderate, heavy, and very
heavy) based on respondents’ job descriptions and the time spent
sitting, standing, walking, and lifting heavy loads during an av-
erage work day. Reported occupations were then cross-tabulated
against these occupational activity levels, and specific metabolic
equivalent (MET) values were assigned based on howmost of the
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respondents reported the activity level of their occupation. Time
spent traveling by each mode and time in inactive and active
leisure activities were collected in detail. In addition, home
activity was measured on the basis of 4 activities: time spent
preparing food, buying food, doing laundry, and on childcare. All
activities were reported in average hours per week spent in the
past year. Time spent in each activity was multiplied by specific
MET values based on the Compendium of Physical Activities
(26). High-quality publications using the CHNS physical activity
measurement method have been generated (22–24, 27, 28). Each
measure of activity has been predictive of weight gain and in-
cident obesity.
Other demographic and lifestyle covariates, including age,
sex, urban residence, region (south or north area), smoking
status, alcohol consumption, education level, and individual
income were measured by questionnaire-based interview in the
surveys.
Overweight definition
In accordance with recommendations of the World Health
Organization (WHO) (29) and the International Association for
the Study of Obesity for Asian populations (30), overweight was
defined as a BMI (in kg/m2)  25.0 in the main analysis and as
a BMI  23.0 in the sensitivity analyses.
Statistical analysis
We used chi-square tests (categorical variables) and analysis of
variance and nonparametric Kruskal-Wallis tests (continuous
variables) to compare the baseline characteristics of participants
according to quintiles of MSG intake. To examine the association
of MSG intake with overweight across households and com-
munities, we used the statistical software MLwiN 2.20 to con-
struct multilevel (4 levels) mixed-effects linear regression models
(BMI) and logistic regression models (overweight) with mea-
surement occasions (level one) nested within individuals (level
2), household (level 3), and community (level 4). These models
enabled us to assess the effects of covariates measured at different
levels of a hierarchy on the outcome. Because the multilevel
model accounts for the clustering of data, it can correct biases in
parameter estimates and provide accurate SEs and thus produce
correct CIs and significance tests (31). The multilevel models also
allow for incomplete outcome data under the missing at random
(MAR) assumption (31). b Regression coefficients (SEs) in the
linear regression and prospective odds ratios (and 95% CIs) in
the logistic regression were calculated for BMI and overweight,
respectively. In addition, we used Cox regression models with
a gamma-distributed random effect representing unobserved
heterogeneity of frailty over household level to examine the
association between MSG intake and incidence of overweight
by using the statistical software STATA 11.0 (StataCorp, Col-
lege Station, TX). We considered 2 sequential models in the
aforementioned analyses: model 1 adjusted for age, sex, urban
residence, and region (south area or north area), and model 2
additionally adjusted for smoking status, alcohol consumption,
individual income inflated to 2006, education, physical activity,
and intakes of total energy, sodium, potassium, and calcium.
Other potential dietary and nondietary confounders were also
considered in sensitivity analyses. In addition, propensity scores
were used to further ensure that the comparison groups are
comparable with multivariable adjustment (32). Furthermore,
a general linear regression model was used to examine the
cross-sectional relation between MSG intake and serum leptin
concentrations in a subcohort. Spearman’s rank correlation
coefficient was computed for the MSG intake validation study.
Two-sided tests were used, and P  0.05 was considered sta-
tistically significant.
RESULTS
The mean duration of follow-up was 5.5 y (48,857 person-
years). The median cumulative MSG intake was 1.8 g/d (mean6
SD: 2.2 6 1.6 g/d). Men had a slightly higher MSG intake than
did the women (median: 1.9 compared with 1.7 g/d; P , 0.01).
In general, participants with a high MSG intake had a higher
BMI and individual income, higher intakes of total energy and
sodium, and lower physical activity levels (Table 1).
MSG consumption was significantly, positively associated
with BMI in a dose-response manner (P for trend ,0.01) after
adjustment for potential confounders and control for clustering
of data at multiple levels (individual, household, and commu-
nity) (Table 2). For participants in the highest compared with
the lowest quintile of MSG intake, the prospective odds ratio of
overweight was 1.28 (95% CI: 1.12, 1.45; P for trend ,0.01)
after baseline BMI and other potential confounders were ad-
justed for (Table 3).
To examine the association betweenMSG intake and incidence
of overweight, we excluded participants who were overweight or
obese at baseline and who had no follow-up data (ie, enrolled in
2006). A total of 824 incident cases of overweight were docu-
mented among 7192 normal-weight participants at baseline.
Compared with those who were in the lowest quintile of MSG
intake, participants in the highest quintile were 33% more likely
to develop overweight [hazard ratio (HR): 1.33; 95% CI: 1.01,
1.75; P for trend ,0.01] independent of baseline BMI and other
potential confounders (Table 4).
The observed associations remained after control for pro-
pensity scores. For instance, the HR in the highest quintile of
MSG intake group related to the first quintile was 1.37 (95% CI:
1.04, 1.80) with adjustment for propensity scores, which were
derived from the same covariates in the multivariable analysis;
the corresponding HR was essentially similar when adjusted for
propensity scores derived from the covariates in the final model
with additional dietary variables such as fiber, carbohydrates, and
total fat. Because men and people in urban areas are more likely
to eat outside, we stratified data by sex and residence. The
associations were generally consistent across subgroups. In ad-
dition, our findings remained when we used BMI 23.0 to define
overweight.
To explore the potential mechanism, we conducted a pilot
study to examine the association between MSG consumption and
serum leptin concentrations among 669 Chinese adults who
participated in the 2006 survey and provided fasting blood
specimens. The median leptin concentration was 7.2 ng/mL
(mean 6 SD: 9.92 6 9.15 ng/mL). MSG intake was positively
related to serum leptin concentrations. After control for the
potential confounders listed in model 2 (Table 2), the serum
leptin concentration increased by 0.45 ng/mL (SE = 0.16, P ,
0.01) with every 1-g increment increase in MSG intake.
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DISCUSSION
In this diverse, large cohort of Chinese men and women, we
found that MSG consumption was positively, longitudinally
related to risk of overweight with adjustment for baseline BMI,
physical activity, total energy intake, and other potential con-
founders, and accounting for clustering data at individual,
household, and community levels.
Strengths and limitations of the study
The major strengths of this study include the large nationwide,
diverse population, prospective follow-up study design, and wide
variation of MSG intake both spatially and temporally. Also, our
findings are further strengthened by a few supportive pilot studies
including the MSG intake validation study, total energy intake
validation study, and exploratory study on the hypothesized
MSG–leptin resistance–obesity pathway. Because of ethical
considerations and other methodologic constraints (eg no proper
placebo), we may not be able to conduct a large-scale, ran-
domized, placebo-controlled clinical trial. Thus, data from a large
cohort study may be very important to advance our knowledge.
In addition to some common weaknesses of any observational
study, eg, confounding from unknown factors, some other lim-
itations also need to be considered. One major concern is the
accuracy of the MSG measurement. Similar to other food
additives (eg, salt), MSG intake is difficult to be captured ac-
curately by any available dietary assessment instruments such as
food frequency questionnaires. In the present study, however,
household MSG consumption was considered accurate because it
was measured by direct weighing of the MSG container before
and after each of three 24-h recalls. The accuracy of MSG intake
for individuals was evaluated using riboflavin as an adherence
marker. Thus, the estimation of MSG intake is unlikely to be
substantially biased, although measurement errors are inevitable
and likely to be nondifferential. For example, data on MSG
content in processed foods are missing. Nevertheless, MSG from
processed foods in Chinese population may be a relatively small
portion as compared with added MSG including MSG from soy
sauce in food preparation. Also, our ability to examine the re-
lation of MSG intake with obesity was limited by the relatively
small number of participants with BMI  30. Presumably,
a positive association between MSG intake and risk of obesity
exists given the linear relation of MSG and BMI. In addition,
loss to follow-up might bias our results, although it is unlikely
that the cases of loss to follow-up are associated with both MSG
intake and overweight.
A recent study found no significant association between MSG
consumption and weight gain among 1282 Chinese men and
women in Jiangsu province, China (33). In addition to the dif-
ferent study population and sample size, its outcome of interest is
5% weight gain rather than BMI, overweight, or obesity. Of note,
MSG intake and weight were only measured twice 5 y apart in the
study and no results on the association of MSG intake with in-
cidence of overweight/obesity were reported. Detailed criticism
on its methodologic flaws was published (34). Our study may
provide more solid evidence given the large, diverse population in
terms of geography, stage of economic development, and health
status.
Recently, debate has arisen over whether MSG intake is a risk
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industry reported that MSG intake would suppress weight gain in
animal models (36). Whereas glutamate industry sponsored
studies have been questioned previously (37, 38), further studies
are clearly warranted.
Potential mechanisms
Whereas the mechanisms are not completely understood,
a hypothesis has been made that chronic MSG intake may induce
pathologic changes of the arcuate nucleus neurons and disrupt the
hypothalamic signaling cascade of leptin action, causing leptin
resistance related to overweight and obesity (15, 16). The arcuate
nucleus is the major site of glutamic acid–induced neuronal
damage in the hypothalamus (39). In addition, leptin is produced
in the adipose tissue, crosses the blood-brain barrier by active
transport systems, and stimulates a specific signaling cascade
(40). The hypothalamic arcuate nucleus is essential for mediating
the anorectic effects of leptin influencing energy balance (8, 9).
Studies suggest that MSG may cause leptin resistance. For in-
stance, leptin production is increased in animal models of obesity
associated with experimentally induced hypothalamic damage,
including the MSG-treated model (41). Also, it was reported that
leptin suppressed body weight gain in controls but did not
suppress weight gain in MSG-treated rats (8), and that leptin
significantly inhibited food intake and caused weight loss in
control rats whereas MSG-treated rats were unresponsive to
leptin treatment (9).
Injected compared with orally administered MSG
Because animal studies suggest that injection or oral adminis-
tration of MSG may induce neuronal necrosis in the hypothalamus
(7, 42–47), concerns have arisen that ingestion of MSG by humans
may contribute to occurrence of neuroendocrinopathies (48, 49).
WhetherMSG ingestion causes hypothalamic damage, however, has
been debated for some time because most of the evidence on
TABLE 4
Multilevel multivariable-adjusted hazard ratios (and 95% CIs) of overweight according to quintile (Q) of monosodium glutamate (MSG) intake (n = 7192)1
MSG intake
Q1 Q2 Q3 Q4 Q5 P for trend
No. of participants 1438 1439 1438 1439 1438
Median of MSG intake (g/d) 0.63 1.18 1.76 2.57 4.19
IQR of MSG intake (g/d) 0.42–0.78 1.04–1.33 1.63–1.94 2.34–2.84 3.58–5.58
No. of overweight participants 86 159 162 208 209
Model 12 1.00 1.05 (0.80, 1.39) 0.88 (0.67, 1.17) 1.04 (0.79, 1.36) 1.40 (1.07, 1.84) ,0.01
Model 23 1.00 1.00 (0.75, 1.32) 0.83 (0.63, 1.10) 0.96 (0.73, 1.27) 1.33 (1.01, 1.75) ,0.01
1 All models were constructed by using Cox regression with gamma shared frailty over the household level. IQR, interquartile range.
2 Adjusted for age, sex, urban residence, and region (south or north area).
3 Adjusted as for model 1 plus smoking status (current or not current), alcohol consumption (yes or no), individual income inflated to 2006 (quintile),
education (missing, 6 y, 7–9 y, or 10 y), physical activity (quintile), and dietary intakes (quintile) of total energy, sodium, potassium, and calcium.
TABLE 3
Multilevel multivariable-adjusted prospective odds ratios (and 95% CIs) of overweight according to quintile (Q) of
monosodium glutamate (MSG) intake (n = 10,095)1
MSG intake (g/d)
Model 12 Model 23Median IQR
Fixed effects
MSG
Q1 0.485 0.267–0.622 1.00 1.00
Q2 0.989 0.847–1.124 1.11 (0.98, 1.25) 1.09 (0.96, 1.24)
Q3 1.655 1.432–1.837 1.07 (0.95, 1.21) 1.06 (0.94, 1.20)
Q4 2.627 2.249–3.091 1.24 (1.10, 1.41) 1.23 (1.08, 1.39)
Q5 5.000 3.975–6.431 1.29 (1.14, 1.47) 1.28 (1.12, 1.45)
P for trend ,0.01 ,0.01
Random effects
Level 4 (r2f ) 0.169 (0.028) 0.158 (0.027)
Level 3 (r2v) 0.194 (0.056) 0.184 (0.056)
Level 2 (r2u) 1.352 (0.080) 1.348 (0.080)
Level 1 ½pijkð12pijkÞ — —
1 All models were constructed by using multilevel (4 levels) mixed-effects logistic regression with the restricted
iterative generalized least-squares estimation method. IQR, interquartile range.
2 Adjusted for age, sex, urban residence, and region (south or north area).
3 Adjusted as for model 1 plus smoking status (current or not current), alcohol consumption (yes or no), individual
income inflated to 2006 (quintile), education (missing, 6 y, 7–9 y, or 10 y), physical activity (quintile), and dietary
intakes (quintile) of total energy, sodium, potassium, and calcium.
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hypothalamic lesions and appetite regulation has been derived from
studies where animals were injected with a large dose of MSG.
Nevertheless, some studies have examined the effects of orally
administered MSG (14, 50–53) and found that oral MSG use at
a level similar to the amount typically added to food had significant
potential of damaging the hypothalamic regulation of appetite (14).
In addition, we conducted a pilot study on MSG intake and serum
leptin concentrations and observed a positive correlation between
these 2 variables. Our pilot data further support the hypothesis that
MSG intake may reduce the sensitivity of leptin or cause leptin
resistance. Further studies are warranted.
Safety compared with health
MSG is considered as a food ingredient that is “generally
recognized as safe” by US FDA. Other health organizations,
including the Federation of American Societies for Experimental
Biology (FASEB) and the World Health Organization (WHO),
have also concluded that MSG is safe as a food additive (54, 55).
None of these evaluations, however, discussed or investigated
MSG as a risk factor for overweight and obesity. Concern about
health impact is different from the issue of safety. Sugar is safe,
but it may not be healthy (56, 57). trans Fat is not toxic, but
sufficient evidence supports that it is a risk factor for heart
disease (58).
Natural compared with processed free glutamic acid
Glutamic acid is one of the most common amino acids and is
recognized as the physiologic ligand of the taste receptor umami,
which is responsible for the immediate sensory effect of MSG on
the palatability of food. One key point that the MSG industry
promotes is that MSG is identical to the glutamic acid in intact
protein and in higher organisms. Of note, there are 2 forms of
glutamic acid found in nature: L-glutamic acid and D-glutamic
acid. Although these 2 enantiomers appear to be identical, chiral
molecules are fundamentally different. The glutamic acid found
in protein is L-glutamic acid only, whereas D-glutamic acid is not
found naturally in higher organisms but only in the cell walls of
certain bacteria (59–61). Manufactured or processed free glu-
tamic acid always contains some D-glutamic acid (59, 62, 63),
which is unavailable for peptide and protein synthesis and may
even inhibit enzymes. Thus, D-configured amino acids should
not be consumed (64). In addition, MSG—the manufactured salt
of glutamic acid—is a single molecule. It does not need the
digestion process and can be absorbed immediately into circu-
lation. In contrast, glutamic acid in unprocessed or natural foods
predominantly exists as a part of protein (polypeptide mole-
cules) or is connected as peptides. Similar to complex carbo-
hydrates, the human digestive system is needed to break down
glutamic acid to free amino acids before the protein or poly-
peptides can pass through the stomach and intestines. Because it
takes longer for the digestive system to break down these pro-
teins or peptides into free amino acids, it may take longer to get
hungry again. Certainly, the potential health impact of this dif-
ference needs to be further investigated. In addition, a few
studies suggest that some natural foods also contain a tiny
amount of free glutamic acid (65). For example, 100 g cod fish
contains 2101 mg bound glutamic acid but only 9 mg free
glutamic acid. Also, 100 g cow milk contains 819 mg bound
glutamic acid but only 2 mg free glutamic acid (65). Despite the
minute amount of free glutamic acid in natural foods, this does
not necessarily mean that the free glutamic acid or MSG is
healthy. A similar example is trans fatty acid—an established
risk factor for heart disease. Although trans fatty acids are
largely produced in processed foods (eg, in foods containing
hydrogenated fat or in deep fried foods), small amounts of trans
fatty acids occur naturally in some meat and dairy products,
including beef, lamb, and butter, although it is not clear whether
these naturally occurring trans fatty acids have the same adverse
effects on human health (66). Thus, naturally occurring, small
amounts of free glutamic acid do not offer sufficient support that
MSG is healthy.
Why are Asians relatively lean compared with Westerners
if MSG is more popular in Asian cuisine?
Data on MSG consumption across countries or populations are
limited. It is generally believed that Asians have higher MSG
consumption because MSG is more popular in Asian cuisine; in
particular, many more Asians than Westerners add MSG in food
preparation. Body weight is a multiinfluenced phenotype,
however, related to lifestyle, environment, and genome and not
determined by a single factor. MSG may be one of numerous
known and unknown risk factors of obesity. The potential adverse
effect of MSG intake on body weight in Asians may be attenuated
by other lifestyle factors, eg, greater physical activity and lower
calorie intake or lower energy density of foods. In addition,
Asians BMIs, waist circumferences, and particularly their vis-
ceral fat are rising rapidly (67). At the same time, MSG con-
sumption has risen as have many other possibly obesogenic
changes have occurred. Notably, people inWestern countries may
also consume substantial amount of MSG by adding seasonings
and other condiments with hidden MSG.
Conclusions
In this large, open-cohort study, we found that MSG intakewas
positively, longitudinally associated with BMI and incidence of
overweight independent of baseline BMI, physical activity, total
energy intake, and other potential confounders among apparently
healthy Chinese adults. Although the magnitude of weight gain in
MSG users compared with nonusers is modest, it is of great
public health significance if the weight gain is solely caused by
MSG intake given that MSG is increasingly used worldwide.
Evidently, further studies are needed to confirm our findings, to
elucidate the mechanisms of action, and to establish causal in-
ference. For example, an MSG cessation intervention may be
warranted.
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